XML 144 R121.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Segment Reporting Information [Line Items]                      
Dialysis and related lab patient service revenues                 $ 10,709,981 $ 10,093,670 $ 9,727,360
Provision for uncollectible accounts                 (49,587) (485,364) (431,304)
Net dialysis and related lab patient service revenues                 10,660,394 9,608,306 9,296,056
Other revenues                 744,457 1,268,328 1,411,411
Total revenues $ 2,821,124 $ 2,847,330 $ 2,886,953 $ 2,849,444 $ 2,780,913 $ 2,765,071 $ 2,699,399 $ 2,631,251 11,404,851 10,876,634 10,707,467
Operating income $ 387,908 $ 289,038 $ 438,192 $ 410,686 $ 150,337 $ 395,294 $ 391,196 $ 875,928 1,525,824 1,812,755 2,029,710
Corporate administrative support                 (90,108) (44,966) (13,628)
Debt expense                 (487,435) (430,634) (414,116)
Other income                 10,089 17,665 7,511
Income from continuing operations before income taxes                 1,048,478 1,399,786 1,623,105
U.S. dialysis and related lab services                      
Segment Reporting Information [Line Items]                      
Total revenues                 10,242,999 9,304,889 9,110,834
Other ancillary services and strategic initiatives                      
Segment Reporting Information [Line Items]                      
Total revenues                 1,161,852 1,571,745 1,596,633
Operating Segments                      
Segment Reporting Information [Line Items]                      
Total revenues                 11,532,037 10,956,413 10,759,561
Operating income                 1,615,932 1,857,721 2,043,338
Operating Segments | U.S. dialysis and related lab services                      
Segment Reporting Information [Line Items]                      
Dialysis and related lab patient service revenues                 10,366,996 9,822,299 9,551,422
Provision for uncollectible accounts                 (50,927) 481,973 (429,878)
Net dialysis and related lab patient service revenues                 10,316,069 9,340,326 9,121,544
Other revenues                 19,880 19,739 16,645
Total revenues                 10,335,949 9,360,065 9,138,189
Operating income                 1,709,721 2,297,198 1,777,014
Operating Segments | U.S. dialysis and related lab services | External Sources                      
Segment Reporting Information [Line Items]                      
Dialysis and related lab patient service revenues                 10,274,046 9,767,123 9,524,067
Operating Segments | U.S. dialysis and related lab services | Intersubsegment Eliminations                      
Segment Reporting Information [Line Items]                      
Dialysis and related lab patient service revenues                 92,950 55,176 27,355
Operating Segments | Other ancillary services and strategic initiatives                      
Segment Reporting Information [Line Items]                      
Dialysis and related lab patient service revenues                 437,275 323,156 201,867
Other revenues                 724,577 1,248,589 1,394,766
Total revenues                 1,196,088 1,596,348 1,621,372
Operating income                 (93,789) (439,477) 266,324
Operating Segments | Other ancillary services and strategic initiatives | Intersubsegment Eliminations                      
Segment Reporting Information [Line Items]                      
Dialysis and related lab patient service revenues                 34,236 24,603 24,739
Intersegment Elimination                      
Segment Reporting Information [Line Items]                      
Total revenues                 (127,186) (79,779) (52,094)
Intersegment Elimination | U.S. dialysis and related lab services                      
Segment Reporting Information [Line Items]                      
Total revenues                 (92,950) (55,176) (27,355)
Intersegment Elimination | Other ancillary services and strategic initiatives                      
Segment Reporting Information [Line Items]                      
Total revenues                 $ (34,236) $ (24,603) $ (24,739)